Apogee secures up to $1.3B non-dilutive financing from Blackstone for zumilokibart

Apogee Therapeutics, Inc.

$100M upfront received; additional $100M upon Phase 3 enrollment, $200M on positive Phase 3 data.
Up to $400M more at FDA approval ($150M at Apogee's option); total synthetic royalty up to $800M.
Low-to-mid single digit tiered royalties for 15 years on worldwide net sales; no royalties above $8B.
Up to $500M senior corporate debt available at mutual consent with Blackstone.
Company removes cash runway guidance; combined with $1.3B current cash positions for self-sustainability.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-066575
form_type: 8-K
ticker: APGE
cik: 0001974640
company_name: Apogee Therapeutics, Inc.
filed_at: 2026-05-27T10:40:32+00:00
discovered_at: 2026-05-27T10:45:01.346592+00:00
generated_at: 2026-05-27T10:45:17.600815+00:00
sec_items: ["1.01", "7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-066575
json_url: https://secwatch.observer/filing/0001104659-26-066575.json
markdown_url: https://secwatch.observer/filing/0001104659-26-066575.md
text_url: https://secwatch.observer/filing/0001104659-26-066575.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1974640/000110465926066575/0001104659-26-066575-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1974640/000110465926066575/tm2615568d2_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

Momentus raises $25M via private placement of common stock at $8.50/share

Momentus Inc. May 29, 2026, 4:51 PM ET other_material Items 1.01, 3.02, 7.01, 9.01

same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

Vireo Growth acquires NY cannabis facility from IIP for $88.5M with $49M seller note and $41M loan

Vireo Growth Inc. May 29, 2026, 4:06 PM ET other_material Items 1.01, 2.03, 7.01, 9.01

same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026

Spectral AI, Inc. June 1, 2026, 4:01 PM ET other_material Items 5.07, 7.01, 9.01